Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Anti-HIV Agents"" wg kryterium: Temat


Tytuł:
The development of a conceptual framework on PrEP stigma among adolescent girls and young women in sub-Saharan Africa.
Autorzy:
Hartmann M; Women's Global Health Imperative, RTI International, Berkeley, California, USA.; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
Nyblade L; Women's Global Health Imperative, RTI International, Berkeley, California, USA.
Otticha S; Impact Research Development Organization, Kisumu, Kenya.
Marton T; Women's Global Health Imperative, RTI International, Berkeley, California, USA.
Agot K; Impact Research Development Organization, Kisumu, Kenya.
Roberts ST; Women's Global Health Imperative, RTI International, Berkeley, California, USA.
Pokaż więcej
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2024 Feb; Vol. 27 (2), pp. e26213.
Typ publikacji:
Review; Journal Article
MeSH Terms:
HIV Infections*/prevention & control
HIV Infections*/drug therapy
Anti-HIV Agents*/therapeutic use
Pre-Exposure Prophylaxis*/methods
Humans ; Adolescent ; Female ; Kenya ; Sexual Behavior
Czasopismo naukowe
Tytuł:
My Way: development and preliminary evaluation of a novel delivery system for PrEP and other sexual health needs of young women in Western Kenya.
Autorzy:
Haberer JE; Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Oware K; Kenya Medical Research Institute, Kisumu, Kenya.
Juma L; Kenya Medical Research Institute, Kisumu, Kenya.
Nyerere B; Kenya Medical Research Institute, Kisumu, Kenya.
Momanyi V; Kenya Medical Research Institute, Kisumu, Kenya.
Odoyo J; Kenya Medical Research Institute, Kisumu, Kenya.
Garrison L; Massachusetts General Hospital, Boston, Massachusetts, USA.
Bhagat J; Ark Africa, Nairobi, Kenya.
Musinguzi N; Global Health Collaborative, Mbarara, Uganda.
Baeten JM; University of Washington, Seattle, Washington, USA.
Siegler A; Emory University, Atlanta, Georgia, USA.
Bukusi EA; Kenya Medical Research Institute, Kisumu, Kenya.; University of Washington, Seattle, Washington, USA.
Pokaż więcej
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2024 Feb; Vol. 27 (2), pp. e26217.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
HIV Infections*/diagnosis
HIV Infections*/prevention & control
HIV Infections*/drug therapy
Anti-HIV Agents*/therapeutic use
Sexual Health*
Sexually Transmitted Diseases*/diagnosis
Sexually Transmitted Diseases*/prevention & control
Pre-Exposure Prophylaxis*
Organophosphates*
Adenine/*analogs & derivatives
Humans ; Female ; Young Adult ; Adult ; Adolescent ; Kenya/epidemiology
Czasopismo naukowe
Tytuł:
Long-term retention on antiretroviral treatment after enrolment in prevention of vertical HIV transmission services: a prospective cohort study in Dar es Salaam, Tanzania.
Autorzy:
Urrio RF; Management and Development for Health, Dar es Salaam, Tanzania.; Department of Obstetrics and Gynacology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Lyatuu GW; Management and Development for Health, Dar es Salaam, Tanzania.; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
Sando D; Management and Development for Health, Dar es Salaam, Tanzania.
Mahande MJ; Management and Development for Health, Dar es Salaam, Tanzania.
Philipo E; Management and Development for Health, Dar es Salaam, Tanzania.
Naburi H; Department of Pediatric and Child Health, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Lyaruu P; Management and Development for Health, Dar es Salaam, Tanzania.
Kimonge A; Management and Development for Health, Dar es Salaam, Tanzania.
Mayogu K; Management and Development for Health, Dar es Salaam, Tanzania.
Simba B; Management and Development for Health, Dar es Salaam, Tanzania.
Kibao AM; Office of the Regional Administrative Secretary, Dar es Salaam, Tanzania.
Msangi M; Ministry of Health, Dodoma, Tanzania.
Zeebari Z; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
Biberfeld G; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
Ekström AM; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.; Department of Infectious Disease/Venhälsan, South General Hospital, Stockholm, Sweden.
Kilewo C; Department of Obstetrics and Gynacology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Kågesten AE; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
Pokaż więcej
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2024 Feb; Vol. 27 (2), pp. e26186.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/drug therapy
HIV Infections*/prevention & control
Anti-HIV Agents*/therapeutic use
Humans ; Female ; Pregnancy ; Child ; Aged ; Prospective Studies ; Tanzania/epidemiology ; Anti-Retroviral Agents/therapeutic use ; Breast Feeding
Czasopismo naukowe
Tytuł:
Body weight and blood pressure changes on dolutegravir-, efavirenz- or atazanavir-based antiretroviral therapy in Zimbabwe: a longitudinal study.
Autorzy:
Shamu T; Newlands Clinic, Harare, Zimbabwe.; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.; Graduate School of Health Sciences, University of Bern, Bern, Switzerland.
Egger M; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.; Centre for Infectious Disease Epidemiology and Research, School of Public Health, University of Cape Town, Cape Town, South Africa.; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Mudzviti T; Newlands Clinic, Harare, Zimbabwe.; Department of Pharmacy and Pharmaceutical Sciences, University of Zimbabwe, Harare, Zimbabwe.
Chimbetete C; Newlands Clinic, Harare, Zimbabwe.
Manasa J; Innovation Hub, University of Zimbabwe, Harare, Zimbabwe.
Anderegg N; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.; Centre for Infectious Disease Epidemiology and Research, School of Public Health, University of Cape Town, Cape Town, South Africa.
Pokaż więcej
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2024 Feb; Vol. 27 (2), pp. e26216.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Hypertension*
Anti-HIV Agents*/adverse effects
Piperazines*
Pyridones*
Alkynes*
Oxazines*
Cyclopropanes*
Adult ; Male ; Humans ; Female ; Longitudinal Studies ; Atazanavir Sulfate/adverse effects ; Blood Pressure ; Zimbabwe/epidemiology ; Bayes Theorem ; Benzoxazines/adverse effects ; Heterocyclic Compounds, 3-Ring/adverse effects ; Weight Gain ; Body Weight
Czasopismo naukowe
Tytuł:
Temporal dynamics and drivers of durable HIV viral load suppression and persistent high- and low-level viraemia during Universal Test and Treat scale-up in Uganda: a population-based study.
Autorzy:
Rosen JG; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Ssekubugu R; Rakai Health Sciences Program, Entebbe, Uganda.
Chang LW; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Rakai Health Sciences Program, Entebbe, Uganda.; Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Ssempijja V; Rakai Health Sciences Program, Entebbe, Uganda.; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
Galiwango RM; Rakai Health Sciences Program, Entebbe, Uganda.
Ssekasanvu J; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Rakai Health Sciences Program, Entebbe, Uganda.
Ndyanabo A; Rakai Health Sciences Program, Entebbe, Uganda.
Kisakye A; Rakai Health Sciences Program, Entebbe, Uganda.
Nakigozi G; Rakai Health Sciences Program, Entebbe, Uganda.
Rucinski KB; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Patel EU; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Kennedy CE; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Rakai Health Sciences Program, Entebbe, Uganda.
Nalugoda F; Rakai Health Sciences Program, Entebbe, Uganda.
Kigozi G; Rakai Health Sciences Program, Entebbe, Uganda.
Ratmann O; Department of Mathematics, Imperial College, London, UK.
Nelson LJ; Division of Global HIV and TB, Centers for Disease Control and Prevention, Kampala, Uganda.
Mills LA; Division of Global HIV and TB, Centers for Disease Control and Prevention, Kampala, Uganda.
Kabatesi D; Division of Global HIV and TB, Centers for Disease Control and Prevention, Kampala, Uganda.
Tobian AAR; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Quinn TC; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Rakai Health Sciences Program, Entebbe, Uganda.; Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Kagaayi J; Rakai Health Sciences Program, Entebbe, Uganda.
Reynolds SJ; Rakai Health Sciences Program, Entebbe, Uganda.; Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Grabowski MK; Rakai Health Sciences Program, Entebbe, Uganda.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Pokaż więcej
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2024 Feb; Vol. 27 (2), pp. e26200.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/diagnosis
HIV Infections*/drug therapy
HIV Infections*/epidemiology
HIV-1*/genetics
Anti-HIV Agents*/therapeutic use
Male ; Female ; Humans ; Cohort Studies ; Uganda/epidemiology ; Viral Load ; Viremia/diagnosis ; Viremia/drug therapy ; Viremia/epidemiology
Czasopismo naukowe
Tytuł:
HIV pre-exposure prophylaxis programme preferences among sexually active HIV-negative transgender and gender diverse adults in the United States: a conjoint analysis.
Autorzy:
Watson DL; Department of Medicine (Infectious Diseases), University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Listerud L; Department of Family and Community Health, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Drab RA; Department of Family and Community Health, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Lin WY; Department of Family and Community Health, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Momplaisir FM; Department of Medicine (Infectious Diseases), University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Bauermeister JA; Department of Family and Community Health, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Pokaż więcej
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2024 Feb; Vol. 27 (2), pp. e26211.
Typ publikacji:
Journal Article
MeSH Terms:
Transgender Persons*
Pre-Exposure Prophylaxis*
HIV Infections*/drug therapy
HIV Infections*/prevention & control
Sexual and Gender Minorities*
Anti-HIV Agents*/therapeutic use
Male ; Adult ; Infant, Newborn ; Humans ; Female ; United States ; Adolescent ; Young Adult ; Middle Aged ; Homosexuality, Male ; Bayes Theorem ; Hormones/therapeutic use
Czasopismo naukowe
Tytuł:
Field performance and cost-effectiveness of a point-of-care triage test for HIV virological failure in Southern Africa.
Autorzy:
Saura-Lázaro A; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Bock P; Department of Pediatrics and Child Health, Desmond Tutu TB Centre, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Bogaart EVD; Mondial Diagnostics, Amsterdam, The Netherlands.
van Vliet J; Mondial Diagnostics, Amsterdam, The Netherlands.
Granés L; Department of Preventive Medicine and Epidemiology, Hospital Clínic de Barcelona, Barcelona, Spain.
Nel K; Department of Pediatrics and Child Health, Desmond Tutu TB Centre, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Naidoo V; Department of Pediatrics and Child Health, Desmond Tutu TB Centre, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Scheepers M; Department of Pediatrics and Child Health, Desmond Tutu TB Centre, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Saunders Y; Department of Pediatrics and Child Health, Desmond Tutu TB Centre, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Leal N; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Ramponi F; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Paulussen R; Mondial Diagnostics, Amsterdam, The Netherlands.
de Wit TR; Amsterdam Institute for Global Health and Development (AIGHD), Amsterdam, The Netherlands.; Department of Global Health, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, The Netherlands.
Naniche D; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
López-Varela E; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Pokaż więcej
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2023 Oct; Vol. 26 (10), pp. e26176.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Infections*/diagnosis
HIV Infections*/drug therapy
Anti-HIV Agents*/therapeutic use
Anti-HIV Agents*/pharmacology
Adult ; Humans ; Chemokine CXCL10/pharmacology ; Chemokine CXCL10/therapeutic use ; Cost-Benefit Analysis ; Point-of-Care Systems ; Triage ; Cross-Sectional Studies ; Africa, Southern ; Viral Load
Czasopismo naukowe
Tytuł:
A community-based dynamic choice model for HIV prevention improves PrEP and PEP coverage in rural Uganda and Kenya: a cluster randomized trial.
Autorzy:
Kakande ER; Infectious Diseases Research Collaboration, Kampala, Uganda.
Ayieko J; Kenya Medical Research Institute, Nairobi, Kenya.
Sunday H; Infectious Diseases Research Collaboration, Kampala, Uganda.
Biira E; Infectious Diseases Research Collaboration, Kampala, Uganda.
Nyabuti M; Kenya Medical Research Institute, Nairobi, Kenya.
Agengo G; Kenya Medical Research Institute, Nairobi, Kenya.
Kabami J; Infectious Diseases Research Collaboration, Kampala, Uganda.; Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Aoko C; Kenya Medical Research Institute, Nairobi, Kenya.
Atuhaire HN; Infectious Diseases Research Collaboration, Kampala, Uganda.
Sang N; Kenya Medical Research Institute, Nairobi, Kenya.
Owaranganise A; Infectious Diseases Research Collaboration, Kampala, Uganda.
Litunya J; Kenya Medical Research Institute, Nairobi, Kenya.
Mugoma EW; Global Programs for Research & Training, Nairobi, Kenya.
Chamie G; Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, California, USA.
Peng J; Department of Biostatistics, University of Washington, Seattle, Washington, USA.
Schrom J; Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, California, USA.
Bacon MC; Department of Health and Human Services, National Institute of Health, Bethesda, Maryland, USA.
Kamya MR; Infectious Diseases Research Collaboration, Kampala, Uganda.; Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Havlir DV; Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, California, USA.
Petersen ML; Division of Biostatistics, University of California Berkeley, Berkeley, California, USA.
Balzer LB; Division of Biostatistics, University of California Berkeley, Berkeley, California, USA.
Pokaż więcej
Corporate Authors:
SEARCH Study Team
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2023 Dec; Vol. 26 (12), pp. e26195.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
HIV Infections*/prevention & control
HIV Infections*/drug therapy
Pre-Exposure Prophylaxis*
Anti-HIV Agents*/therapeutic use
Humans ; Female ; Male ; Kenya/epidemiology ; Uganda ; HIV Testing ; Self-Testing
Czasopismo naukowe
Tytuł:
Population-level effectiveness of pre-exposure prophylaxis for HIV prevention among men who have sex with men in Montréal (Canada): a modelling study of surveillance and survey data.
Autorzy:
Doyle CM; Department of Epidemiology and Biostatistics, School of Population and Global Health, McGill University, Montréal, Québec, Canada.
Milwid RM; Department of Epidemiology and Biostatistics, School of Population and Global Health, McGill University, Montréal, Québec, Canada.
Cox J; Department of Epidemiology and Biostatistics, School of Population and Global Health, McGill University, Montréal, Québec, Canada.; Direction Régionale de Santé Publique de Montréal, Montréal, Québec, Canada.; Clinical Outcomes Research and Evaluation, Research Institute - McGill University Health Centre, Montréal, Québec, Canada.
Xia Y; Department of Epidemiology and Biostatistics, School of Population and Global Health, McGill University, Montréal, Québec, Canada.
Lambert G; Direction Régionale de Santé Publique de Montréal, Montréal, Québec, Canada.
Tremblay C; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montréal, Québec, Canada.
Otis J; Département de Sexologie, Université du Québec à Montréal, Montréal, Québec, Canada.
Boily MC; MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.
Baril JG; Department of Family Medicine, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.; Clinique de médecine urbaine du Quartier Latin, Montréal, Québec, Canada.
Thomas R; Clinique médicale l'Actuel, Montréal, Québec, Canada.
Blais AD; RÉZO Health and STI prevention for GBQ men, trans people and MSM, Montréal, Québec, Canada.
Trottier B; Clinique de médecine urbaine du Quartier Latin, Montréal, Québec, Canada.
Grace D; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Moore DM; BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Mishra S; Department of Medicine, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.; Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada.; Institute of Health Policy Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Maheu-Giroux M; Department of Epidemiology and Biostatistics, School of Population and Global Health, McGill University, Montréal, Québec, Canada.
Pokaż więcej
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2023 Dec; Vol. 26 (12), pp. e26194.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/epidemiology
HIV Infections*/prevention & control
Pre-Exposure Prophylaxis*/methods
Sexual and Gender Minorities*
Anti-HIV Agents*/therapeutic use
Male ; Humans ; Aged ; Homosexuality, Male ; Pandemics ; Sexual Behavior ; Canada/epidemiology
Czasopismo naukowe
Tytuł:
PrEP initiation and discontinuation among transgender women in the United States: a longitudinal, mixed methods cohort study.
Autorzy:
Cooney EE; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Saleem HT; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Stevenson M; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Aguayo-Romero RA; Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Fenway Health, The Fenway Institute, Boston, Massachusetts, USA.
Althoff KN; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Poteat TC; Department of Social Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.
Beckham SW; Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Adams D; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Radix AE; Callen-Lorde Community Health Center, New York, New York, USA.
Wawrzyniak AJ; Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, Florida, USA.
Cannon CM; Whitman-Walker Institute, Washington, DC, USA.
Schneider JS; Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Haw JS; Division of Endocrinology, Metabolism and Lipids, Emory University School of Medicine, Atlanta, Georgia, USA.
Rodriguez AE; Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA.
Mayer KH; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Fenway Health, The Fenway Institute, Boston, Massachusetts, USA.
Beyrer C; Duke University, Global Health Institute, Durham, North Carolina, USA.
Reisner SL; Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Fenway Health, The Fenway Institute, Boston, Massachusetts, USA.; Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, Massachusetts, USA.
Wirtz AL; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Pokaż więcej
Corporate Authors:
American Cohort to Study HIV Acquisition Among Transgender Women (LITE) Study Group
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2023 Dec; Vol. 26 (12), pp. e26199.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/epidemiology
HIV Infections*/prevention & control
HIV Infections*/drug therapy
Sexually Transmitted Diseases*/epidemiology
Transgender Persons*
Anti-HIV Agents*/therapeutic use
Pre-Exposure Prophylaxis*/methods
Male ; Humans ; Female ; United States/epidemiology ; Cohort Studies ; Homosexuality, Male ; Prospective Studies
Czasopismo naukowe
Tytuł:
Breaking down relationship barriers to increase PrEP uptake and adherence among adolescent girls and young women in Kenya: safety and preliminary effectiveness results from a pilot cluster-randomized trial.
Autorzy:
Roberts ST; Women's Global Health Imperative, RTI International, Berkeley, California, USA.
Hartmann M; Women's Global Health Imperative, RTI International, Berkeley, California, USA.
Minnis AM; Women's Global Health Imperative, RTI International, Berkeley, California, USA.
Otticha SO; Impact Research and Development Organization, Kisumu, Kenya.
Browne EN; Women's Global Health Imperative, RTI International, Berkeley, California, USA.
Montgomery ET; Women's Global Health Imperative, RTI International, Berkeley, California, USA.
Agot K; Impact Research and Development Organization, Kisumu, Kenya.
Pokaż więcej
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2023 Dec; Vol. 26 (12), pp. e26198.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
Intimate Partner Violence*/prevention & control
Pre-Exposure Prophylaxis*/methods
Adolescent ; Female ; Humans ; Young Adult ; Kenya/epidemiology ; Longitudinal Studies
Czasopismo naukowe
Tytuł:
How a menu of adherence support strategies facilitated high adherence to HIV prevention products among adolescent girls and young women in sub-Saharan Africa: a mixed methods analysis.
Autorzy:
Roberts ST; Women's Global Health Imperative, RTI International, Berkeley, California, USA.
Mancuso N; Women's Global Health Imperative, RTI International, Atlanta, Georgia, USA.
Williams K; Applied Public Health Research Center, RTI International, Research Triangle Park, North Carolina, USA.
Nabunya HK; Makerere University-Johns Hopkins University Research Collaboration, Kampala, Uganda.
Mposula H; Wits Reproductive Health and HIV Institute, Johannesburg, South Africa.
Mugocha C; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe.
Mvinjelwa P; Desmond Tutu HIV Centre, Cape Town, South Africa.
Garcia M; FHI 360, Durham, North Carolina, USA.
Szydlo DW; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Soto-Torres L; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Ngure K; School of Public Health, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya.; Department of Global Health, University of Washington, Seattle, Washington, USA.
Hosek S; Center for Dissemination and Implementation Science, University of Illinois Chicago, Chicago, Illinois, USA.
Pokaż więcej
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2023 Nov; Vol. 26 (11), pp. e26189.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
HIV Infections*/prevention & control
Pre-Exposure Prophylaxis*/methods
Adolescent ; Female ; Humans ; Counseling ; South Africa ; Zimbabwe ; Young Adult ; Cross-Over Studies
Czasopismo naukowe
Tytuł:
Impact of point-of-care HIV viral load and targeted drug resistance mutation testing on viral suppression among Kenyan pregnant and postpartum women: results from a prospective cohort study (Opt4Mamas).
Autorzy:
Patel RC; Department of Medicine, University of Washington, Seattle, Washington, USA.; Department of Global Health, University of Washington, Seattle, Washington, USA.; Department of Medicine, University of Alabama, Birmingham, UK.
Oyaro P; Health Innovations Kenya (HIK), Kisumu, Kenya.
Thomas KK; Department of Global Health, University of Washington, Seattle, Washington, USA.
Basha GW; Department of Medicine, University of Washington, Seattle, Washington, USA.
Wagude J; Department of Health, Siaya County, Kenya.
Mukui I; Drugs for Neglected Diseases Initiative (DNDI), Nairobi, Kenya.
Brown E; UWKenya, Nairobi, Kenya.
Hassan SA; Department of Medicine, University of Washington, Seattle, Washington, USA.
Kinywa E; Department of Health, Kisumu County, Kenya.
Oluoch F; Department of Health, Kisumu County, Kenya.
Odhiambo F; Family AIDS Care and Education Services, Kenya Medical Research Institute, Kisumu, Kenya.
Oyaro B; Kenya Medical Research Institute-CDC, Kisian, Kenya.
Kingwara L; National HIV Reference Laboratory, Kenya Ministry of Health, Nairobi, Kenya.
Karauki E; UWKenya, Nairobi, Kenya.
Yongo N; UWKenya, Nairobi, Kenya.
Otieno L; Family AIDS Care and Education Services, Kenya Medical Research Institute, Kisumu, Kenya.
John-Stewart GC; Department of Medicine, University of Washington, Seattle, Washington, USA.; Department of Global Health, University of Washington, Seattle, Washington, USA.; Departments of Pediatrics and Epidemiology, University of Washington, Seattle, Washington, USA.
Abuogi LL; Department of Pediatrics, University of Colorado, Denver, Colorado, USA.
Pokaż więcej
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2023 Nov; Vol. 26 (11), pp. e26182.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/drug therapy
Anti-HIV Agents*/therapeutic use
Infant ; Humans ; Pregnancy ; Female ; Kenya ; Prospective Studies ; Point-of-Care Systems ; Viral Load ; Postpartum Period
Czasopismo naukowe
Tytuł:
"They test my blood to know how much blood is in my body": the untapped potential of promoting viral load literacy to support adherence and viral suppression among adolescents living with HIV.
Autorzy:
Bernays S; School of Public Health, University of Sydney, Sydney, New South Wales, Australia.; Department of Global Health and Development London School of Hygiene & Tropical Medicine, London, UK.
Lariat J; School of Public Health, University of Sydney, Sydney, New South Wales, Australia.
Cowan F; Liverpool School of Tropical Medicine, Liverpool, UK.
Senzanje B; UNICEF, Harare, Zimbabwe.
Willis N; Zvandiri, Harare, Zimbabwe.
Nenguke ZM; Centre for Sexual Health, HIV/AIDS Research (CeSHHAR), Harare, Zimbabwe.
Pokaż więcej
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2023 Oct; Vol. 26 (10), pp. e26153.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Infections*
Anti-HIV Agents*/therapeutic use
Humans ; Adolescent ; Viral Load ; Literacy ; Quality of Life ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Achieving equity for children and adolescents with perinatal HIV exposure: an urgent need for a paradigm shift.
Autorzy:
Mutanga JN; Department of Pediatrics and Child Health, Livingstone Central Hospital, Livingstone, Zambia.
Ronan A; Paediatric Adolescent Treatment Africa, Cape Town, South Africa.
Powis KM; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Departments of Internal Medicine and Pediatrics, Massachusetts General Hospital, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2023 Oct; Vol. 26 Suppl 4, pp. e26171.
Typ publikacji:
Editorial
MeSH Terms:
HIV Infections*/drug therapy
HIV Infections*/epidemiology
HIV Infections*/prevention & control
Anti-HIV Agents*/therapeutic use
Pregnancy Complications, Infectious*/drug therapy
Pregnancy ; Female ; Humans ; Child ; Adolescent ; Infectious Disease Transmission, Vertical/prevention & control
Opinia redakcyjna
Tytuł:
Telehealth effectiveness for pre-exposure prophylaxis delivery in Brazilian public services: the Combine! Study.
Autorzy:
Grangeiro A; Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Santos LAD; Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Estevam DL; Centro de Referência e Treinamento DST/Aids, São Paulo, Brazil.
Munhoz R; Centro de Referência e Treinamento DST/Aids, São Paulo, Brazil.
Arruda É; Hospital São José de Doenças Infecciosas, Fortaleza, Brazil.
de Moraes RA; Hospital São José de Doenças Infecciosas, Fortaleza, Brazil.
de Quadros Winkler L; Serviço de Atenção Especializada do Centro de Saúde IAPI, Porto Alegre, Brazil.
Neves LAS; Prefeitura Municipal de Ribeirão Preto, Ribeirão Preto, São Paulo, Brazil.
Santos JCV; Centro de Orientação e Aconselhamento, Curitiba, Brazil.
Kruppa M; Centro de Orientação e Aconselhamento, Curitiba, Brazil.
Zucchi EM; Programa de Pós-Graduação em Saúde Coletiva, Universidade Catolica de Santos, Santos, São Paulo, Brazil.
Escuder MM; Instituto de Saúde, Secretaria de Estado da Saúde de São Paulo, São Paulo, Brazil.
Leal AF; Instituto de Filosofia e Ciências Humanas, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Koyama MAH; Kamiyama Consultoria em Estatística Ltda, São Paulo, Brazil.
Peres MFT; Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Couto MT; Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Neto JE; Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Pokaż więcej
Corporate Authors:
Combine! Research Group
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2023 Sep; Vol. 26 (9), pp. e26173.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Infections*/drug therapy
HIV Infections*/prevention & control
Pre-Exposure Prophylaxis*
Anti-HIV Agents*/therapeutic use
Telemedicine*
Sexual and Gender Minorities*
Male ; Humans ; Homosexuality, Male ; Brazil
Czasopismo naukowe
Tytuł:
Factors that influence adolescent girls and young women's re-initiation or complete discontinuation from daily oral PrEP use: a qualitative study from Eastern Cape Province, South Africa.
Autorzy:
de Vos L; Research Unit, Foundation for Professional Development, East London, South Africa.
Mudzingwa EK; The Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.; Institute for Collaboration on Health, Intervention, and Policy, University of Connecticut, Storrs, Connecticut, USA.
Fynn L; The Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.
Atujuna M; The Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.
Mugore M; Mailman School of Public Health, Columbia University, New York, New York, USA.
Gandhi M; Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
Celum C; Departments of Global Health, Medicine, and Epidemiology, University of Washington, Seattle, Washington, USA.
Hosek S; Division of Infectious Diseases, Stroger Hospital of Cook County, Chicago, Illinois, USA.; Division of Child and Adolescent Psychiatry, Department of Psychiatry, Stroger Hospital of Cook County, Chicago, Illinois, USA.
Bekker LG; The Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.
Daniels J; Edson College of Nursing and Health Innovation, Arizona State University, Phoenix, Arizona, USA.
Medina-Marino A; The Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Pokaż więcej
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2023 Sep; Vol. 26 (9), pp. e26175.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Infections*/drug therapy
HIV Infections*/prevention & control
Anti-HIV Agents*/therapeutic use
Pre-Exposure Prophylaxis*
Humans ; Female ; Adolescent ; South Africa ; Qualitative Research
Czasopismo naukowe
Tytuł:
Clinical outcomes after extended 12-month antiretroviral therapy prescriptions in a community-based differentiated HIV service delivery programme in South Africa: a retrospective cohort study.
Autorzy:
Lewis L; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.; Department of Statistical Sciences, University of Cape Town, Cape Town, South Africa.
Sookrajh Y; eThekwini Municipality Health Unit, eThekwini Municipality, Durban, South Africa.
van der Molen J; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.
Khubone T; eThekwini Municipality Health Unit, eThekwini Municipality, Durban, South Africa.
Sosibo P; eThekwini Municipality Health Unit, eThekwini Municipality, Durban, South Africa.
Maraj M; eThekwini Municipality Health Unit, eThekwini Municipality, Durban, South Africa.
van Heerden R; eThekwini Municipality Health Unit, eThekwini Municipality, Durban, South Africa.
Little F; Department of Statistical Sciences, University of Cape Town, Cape Town, South Africa.
Kassanjee R; Centre for Infectious Disease Epidemiology and Research, School of Public Health, University of Cape Town, Cape Town, South Africa.
Garrett N; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.; Discipline of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa.
Dorward J; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Pokaż więcej
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2023 Sep; Vol. 26 (9), pp. e26164.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Infections*/drug therapy
Anti-HIV Agents*/therapeutic use
COVID-19*
Humans ; Female ; Adolescent ; Adult ; Male ; Retrospective Studies ; South Africa ; Pandemics ; Community Health Services ; Viral Load
Czasopismo naukowe
Tytuł:
Clients in Uganda accessing preferred differentiated antiretroviral therapy models achieve higher viral suppression and are less likely to miss appointments: a cross-sectional analysis.
Autorzy:
Nkolo EKK; U.S. Agency for International Development (USAID), Kampala, Uganda.
Ejike JC; GHTASC, Credence Management Solutions LLC, supporting the United States Agency for International Development (USAID), Office of HIV/AIDS, Washington, DC, United States.
Sensalire S; University Research Co., LLC, USAID RHITES N-Acholi Activity Kampala, Kampala, Uganda.
Ssali JN; University Research Co., LLC, USAID RHITES N-Acholi Activity Kampala, Kampala, Uganda.
Ddumba I; U.S. Agency for International Development (USAID), Kampala, Uganda.
Calnan J; U.S. Agency for International Development (USAID), Kampala, Uganda.
Gonzalez C; GHTASC, Credence Management Solutions LLC, supporting the United States Agency for International Development (USAID), Office of HIV/AIDS, Washington, DC, United States.
Maina N; GHTASC, Credence Management Solutions LLC, supporting the United States Agency for International Development (USAID), Office of HIV/AIDS, Washington, DC, United States.
Dessie M; U.S. Agency for International Development (USAID), Office of HIV/AIDS, Prevention Care and Treatment Division, Washington, DC, USA.
Bailey L; GHTASC, Credence Management Solutions LLC, supporting the United States Agency for International Development (USAID), Office of HIV/AIDS, Washington, DC, United States.
Amanyeiwe U; GHTASC, Credence Management Solutions LLC, supporting the United States Agency for International Development (USAID), Office of HIV/AIDS, Washington, DC, United States.
Minior T; U.S. Agency for International Development (USAID), Office of HIV/AIDS, Prevention Care and Treatment Division, Washington, DC, USA.
Srikanth K; GHTASC, Credence Management Solutions LLC, supporting the United States Agency for International Development (USAID), Office of HIV/AIDS, Washington, DC, United States.
Kadama H; Ministry of Health, AIDS Control Program, Kampala, Uganda.
Patel K; Brown University [USAID Intern], Providence, Rhode Island, USA.
Patel D; GHTASC, Credence Management Solutions LLC, supporting the United States Agency for International Development (USAID), Office of HIV/AIDS, Washington, DC, United States.
Pokaż więcej
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2023 Jul; Vol. 26 Suppl 1, pp. e26122.
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
HIV Infections*/drug therapy
Anti-HIV Agents*/therapeutic use
Humans ; Cross-Sectional Studies ; Uganda ; Health Facilities
Czasopismo naukowe
Tytuł:
Uptake of a patient-centred dynamic choice model for HIV prevention in rural Kenya and Uganda: SEARCH SAPPHIRE study.
Autorzy:
Kabami J; Infectious Diseases Research Collaboration, Kampala, Uganda.; Department of Medicine, Makerere University, Kampala, Uganda.
Kakande E; Infectious Diseases Research Collaboration, Kampala, Uganda.
Chamie G; Department of Medicine, University of California, San Francisco, California, USA.
Balzer LB; Department of Biostatistics, University of California, Berkeley, California, USA.
Petersen ML; Department of Biostatistics, University of California, Berkeley, California, USA.
Camlin CS; Department of Obstetrics, Gynecology & Reproductive Sciences, University of California, San Francisco, California, USA.
Nyabuti M; Center for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
Koss CA; Department of Medicine, University of California, San Francisco, California, USA.
Bukusi EA; Center for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
Kamya MR; Department of Medicine, Makerere University, Kampala, Uganda.
Havlir DV; Department of Medicine, University of California, San Francisco, California, USA.
Ayieko J; Center for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
Pokaż więcej
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2023 Jul; Vol. 26 Suppl 1, pp. e26121.
Typ publikacji:
Randomized Controlled Trial; Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
HIV Infections*/prevention & control
HIV Infections*/drug therapy
Pre-Exposure Prophylaxis*
Anti-HIV Agents*/therapeutic use
Adult ; Humans ; Male ; Female ; Pregnancy ; Young Adult ; Kenya ; Uganda ; Delivery of Health Care ; Ambulatory Care Facilities
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies